BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 7831358)

  • 1. Studies on the inflammatory-coagulant axis in the baboon response to E. coli: regulatory roles of proteins C, S, C4bBP and of inhibitors of tissue factor.
    Taylor FB
    Prog Clin Biol Res; 1994; 388():175-94. PubMed ID: 7831358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The inflammatory-coagulant axis in the host response to gram-negative sepsis: regulatory roles of proteins and inhibitors of tissue factor.
    Taylor FB
    New Horiz; 1994 Nov; 2(4):555-65. PubMed ID: 7804804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein C.
    Esmon CT
    Prog Hemost Thromb; 1984; 7():25-54. PubMed ID: 6099583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock.
    Carr C; Bild GS; Chang AC; Peer GT; Palmier MO; Frazier RB; Gustafson ME; Wun TC; Creasey AA; Hinshaw LB
    Circ Shock; 1994 Nov; 44(3):126-37. PubMed ID: 7600636
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Staging of the pathophysiologic responses of the primate microvasculature to Escherichia coli and endotoxin: examination of the elements of the compensated response and their links to the corresponding uncompensated lethal variants.
    Taylor FB
    Crit Care Med; 2001 Jul; 29(7 Suppl):S78-89. PubMed ID: 11445739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of coagulation inhibitors in inflammation.
    Esmon CT
    Thromb Haemost; 2001 Jul; 86(1):51-6. PubMed ID: 11487041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C4b-binding protein exacerbates the host response to Escherichia coli.
    Taylor F; Chang A; Ferrell G; Mather T; Catlett R; Blick K; Esmon CT
    Blood; 1991 Jul; 78(2):357-63. PubMed ID: 1829967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock.
    Creasey AA; Chang AC; Feigen L; Wün TC; Taylor FB; Hinshaw LB
    J Clin Invest; 1993 Jun; 91(6):2850-60. PubMed ID: 8514893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of the inflammatory response on coagulation.
    Esmon CT
    Thromb Res; 2004; 114(5-6):321-7. PubMed ID: 15507261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microthrombosis in sepsis.
    Vallet B
    Minerva Anestesiol; 2001 Apr; 67(4):298-301. PubMed ID: 11376528
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.
    Wada H; Yamamuro M; Inoue A; Shiku H; Sakuragawa N; Redl H; Peer G; Taylor FB
    Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between inflammation and thrombosis.
    Esmon CT
    Maturitas; 2004 Apr; 47(4):305-14. PubMed ID: 15063484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anticoagulant and fibrinolytic systems of the injured vascular endothelial cells].
    Takeya H; Suzuki K
    Rinsho Byori; 1994 Apr; 42(4):333-9. PubMed ID: 8176840
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli--a comparative study of treated and untreated non-surviving baboons challenged with LD100 E. coli.
    Randolph MM; White GL; Kosanke SD; Bild G; Carr C; Galluppi G; Hinshaw LB; Taylor FB
    Thromb Haemost; 1998 May; 79(5):1048-53. PubMed ID: 9609245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of the tissue factor/factor VIIa pathway does not influence the inflammatory or antibacterial response to abdominal sepsis induced by Escherichia coli in mice.
    Weijer S; Schoenmakers SH; Florquin S; Levi M; Vlasuk GP; Rote WE; Reitsma PH; Spek CA; van der Poll T
    J Infect Dis; 2004 Jun; 189(12):2308-17. PubMed ID: 15181580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure and biology of tissue factor pathway inhibitor.
    Bajaj MS; Birktoft JJ; Steer SA; Bajaj SP
    Thromb Haemost; 2001 Oct; 86(4):959-72. PubMed ID: 11686353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coagulation and fibrinolytic responses of baboons after in vivo thrombin generation--effect of interleukin 6.
    Kruithof EK; Mestries JC; Gascon MP; Ythier A
    Thromb Haemost; 1997 May; 77(5):905-10. PubMed ID: 9184401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation and thrombosis: the impact of inflammation on the protein C anticoagulant pathway.
    Esmon CT
    Haematologica; 1995; 80(2 Suppl):49-56. PubMed ID: 7628771
    [No Abstract]   [Full Text] [Related]  

  • 19. Sequential renal alterations in septic shock in the primate.
    Voss BL; De Bault LE; Blick KE; Chang AC; Stiers DL; Hinshaw LB; Taylor FB
    Circ Shock; 1991 Mar; 33(3):142-55. PubMed ID: 1904322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased protein S activity in sickle cell disease.
    Marfaing-Koka A; Boyer-Neumann C; Wolf M; Leroy-Matheron C; Cynober T; Tchernia G
    Nouv Rev Fr Hematol (1978); 1993 Aug; 35(4):425-30. PubMed ID: 8414963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.